Patents by Inventor Adam Bilney

Adam Bilney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070203445
    Abstract: In a method for substantially isolating cardiac circulation from systemic circulation, flow between the coronary sinus and the right atrium is occluded. A venous collection device having a collection lumen and a support structure is located in the coronary sinus. The support structure is used to maintain patency of the coronary sinus during collection of fluid through the collection lumen. An artificial flow path is provided between the collection lumen and the one or more coronary arteries, thus isolating the cardiac circulation. According to the method, cardiac pumping for systemic circulation can be maintained during isolation of the cardiac circulation.
    Type: Application
    Filed: August 25, 2006
    Publication date: August 30, 2007
    Applicant: V-KARDIA PTY LTD
    Inventors: David Kaye, Clifton Alferness, John Power, Adam Bilney
  • Publication number: 20070060907
    Abstract: A method for treating an occlusion in a coronary artery of a patient includes percutaneously advancing an occlusion treatment tool (such as an angioplasty balloon or stent delivery device) through the vasculature of the patient and into a coronary artery to a site of the occlusion. Following the treatment of the occlusion, a therapeutic agent is admitted into the first coronary artery. The therapeutic agent is selected to treat microvasculature obstructions at a target cardiac tissue site distal to the site of the occlusion.
    Type: Application
    Filed: July 20, 2006
    Publication date: March 15, 2007
    Inventors: James Shapland, Tuan Doan, David Kaye, Adam Bilney, Melissa Byrne
  • Publication number: 20060148742
    Abstract: A method for delivering a polynucleotide to cardiac tissue, including substantially isolating the coronary venous circulation from systemic circulation, and introducing a polynucleotide into the isolated coronary venous circulation to effect localized transfection of cardiac tissue. The polynucleotide advantageously produces a therapeutic effect, such as increasing or decreasing the expression level of a protein in the cardiac tissue.
    Type: Application
    Filed: August 25, 2005
    Publication date: July 6, 2006
    Inventors: David Kaye, John Power, Clifton Alferness, Adam Bilney, Kenneth Chien, Athanasios Preovolos